Wordt geladen...
Sacubitril–valsartan in heart failure and multimorbidity patients
AIMS: The poor control of symptoms in patients with advanced heart failure with reduced ejection function (HFrEF) can limit the functionality of patients. Sacubitril–valsartan, compared with enalapril, has been shown to reduce mortality and hospitalization, and nowadays, there is still little eviden...
Bewaard in:
| Gepubliceerd in: | ESC Heart Fail |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley and Sons Inc.
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6165940/ https://ncbi.nlm.nih.gov/pubmed/30039930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12338 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|